122 related articles for article (PubMed ID: 21139387)
1. [Primary care enlightenment to local inhabitants--cooperation of medical institution and community pharmacy in treatment of chronic hepatitis C].
Iizuka T; Eguchi Y; Akase T; Ishizuka H; Yoshiyama Y
Yakugaku Zasshi; 2010 Dec; 130(12):1633-9. PubMed ID: 21139387
[TBL] [Abstract][Full Text] [Related]
2. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
Demirturk N; Aykin N; Demirdal T; Cevik F
Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
[No Abstract] [Full Text] [Related]
3. Peginterferon alpha-2a (40 KD) plus ribavirin for the treatment of chronic hepatitis C in Japanese patients.
Kuboki M; Iino S; Okuno T; Omata M; Kiyosawa K; Kumada H; Hayashi N; Sakai T
J Gastroenterol Hepatol; 2007 May; 22(5):645-52. PubMed ID: 17444850
[TBL] [Abstract][Full Text] [Related]
4. Patient education and treatment strategies implemented at a pharmacist-managed hepatitis C virus clinic.
Kolor B
Pharmacotherapy; 2005 Sep; 25(9):1230-41. PubMed ID: 16164396
[TBL] [Abstract][Full Text] [Related]
5. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
Hu CC; Chien RN
Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
[No Abstract] [Full Text] [Related]
6. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
7. Peginterferon and ribavirin for chronic hepatitis C.
Hoofnagle JH; Seeff LB
N Engl J Med; 2006 Dec; 355(23):2444-51. PubMed ID: 17151366
[No Abstract] [Full Text] [Related]
8. Summaries for patients. Re-treating patients with chronic hepatitis C who have not responded to peginterferon-alpha2b.
Ann Intern Med; 2009 Apr; 150(8):I-34. PubMed ID: 19380849
[No Abstract] [Full Text] [Related]
9. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
[TBL] [Abstract][Full Text] [Related]
10. [Combination therapy for chronic viral hepatitis C].
Zeuzem S
Dtsch Med Wochenschr; 2003 Feb; 128(8):370-4. PubMed ID: 12594622
[No Abstract] [Full Text] [Related]
11. Triple therapy of interferon and ribavirin with zinc supplementation for patients with chronic hepatitis C: a randomized controlled clinical trial.
Suzuki H; Takagi H; Sohara N; Kanda D; Kakizaki S; Sato K; Mori M;
World J Gastroenterol; 2006 Feb; 12(8):1265-9. PubMed ID: 16534882
[TBL] [Abstract][Full Text] [Related]
12. Community nurse-led initiation of antiviral therapy for chronic hepatitis C in people who inject drugs does not increase uptake of or adherence to treatment.
Lewis H; Kunkel J; Axten D; Dalton J; Gardner H; Tippett A; Wynne S; Wilkinson M; Foster GR
Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1258-63. PubMed ID: 27487966
[TBL] [Abstract][Full Text] [Related]
13. [New class of medicines for chronic hepatitis C].
Aronson SJ; de Bruijne J; Schinkel J; Weegink CJ; van der Valk M; Reesink HW
Ned Tijdschr Geneeskd; 2012; 156(10):A3840. PubMed ID: 22394440
[TBL] [Abstract][Full Text] [Related]
14. Combined antiviral therapy of hepatitis C virus in dialysis patients: meta-analysis of clinical trials.
Fabrizi F; Dixit V; Martin P; Messa P
J Viral Hepat; 2011 Jul; 18(7):e263-9. PubMed ID: 21108701
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C].
Zhdanov KV; Gusev DA; Kozlov KV; Shishkin MK; Sukachev VS; Shakhmanov DM; Zhabrov SS
Voen Med Zh; 2015 Apr; 336(4):44-9. PubMed ID: 26454938
[TBL] [Abstract][Full Text] [Related]
16. Aminoadamantanes for chronic hepatitis C.
Lamers MH; Broekman M; Drenth JP; Gluud C
Cochrane Database Syst Rev; 2014 May; 2014(5):CD010125. PubMed ID: 24793264
[TBL] [Abstract][Full Text] [Related]
17. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
[TBL] [Abstract][Full Text] [Related]
18. DEPRESSIVE EPISODE INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN.
Vabo IL; Ferreira LE; Pace FH
Arq Gastroenterol; 2016; 53(1):20-4. PubMed ID: 27281500
[TBL] [Abstract][Full Text] [Related]
19. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
[TBL] [Abstract][Full Text] [Related]
20. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK
Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
[No Abstract] [Full Text] [Related]
[Next] [New Search]
